COFCO Biotechnology Co., Ltd. (SHE:000930)

COFCO Biotechnology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,667	1,481	1,017	1,116	662.33	700.48
Trading Asset Securities	-	2.12	3.82	1.86	-	0.71
Cash & Short-Term Investments	1,667	1,483	1,020	1,118	662.33	701.19
Cash Growth	2.59%	45.35%	-8.71%	68.77%	-5.54%	-9.31%
Accounts Receivable	1,584	1,124	1,370	1,189	886.37	975.08
Other Receivables	95.12	196	168.42	293.76	456.98	467.52
Receivables	1,679	1,320	1,538	1,483	1,343	1,443
Inventory	2,196	2,534	3,763	4,052	4,991	2,770
Other Current Assets	1,252	698.26	1,349	982.02	2,904	1,814
Total Current Assets	6,794	6,035	7,671	7,635	9,901	6,728
Property, Plant & Equipment	8,549	8,632	8,611	8,515	8,494	8,151
Long-Term Investments	529	535.39	536.93	512.12	517.34	565.72
Goodwill	366.04	366.04	366.04	366.04	366.04	366.04
Other Intangible Assets	604.78	601.15	609.08	628.96	851.65	823.16
Long-Term Deferred Tax Assets	253.21	265.01	193.49	202.99	133.31	131.69
Long-Term Deferred Charges	45.39	41.94	31.31	25.23	22.22	27.17
Other Long-Term Assets	39	80.94	110.52	171.76	198.8	363.88
Total Assets	17,180	16,558	18,129	18,057	20,484	17,157
Accounts Payable	795.61	766.49	919.59	920.25	845.8	854.84
Accrued Expenses	170.63	262.96	360.15	418.44	499.97	432.94
Short-Term Debt	3,610	3,217	2,874	2,764	6,595	2,532
Current Portion of Long-Term Debt	58.79	44.93	42.67	86.61	45.71	175.34
Current Portion of Leases	-	19.18	12.08	20.81	-	23.95
Current Income Taxes Payable	89.92	47.59	61.58	35	71.42	34.16
Current Unearned Revenue	199.41	266.39	278.73	328.64	364.89	323.53
Other Current Liabilities	737.27	517.47	612.33	1,015	901.02	2,164
Total Current Liabilities	5,662	5,142	5,162	5,589	9,323	6,541
Long-Term Debt	190.34	165.65	191.28	406.4	189.7	274.72
Long-Term Leases	189.48	196.64	105.63	117.3	-	12.22
Long-Term Unearned Revenue	90.29	70.01	72.6	113.79	92.77	67.49
Long-Term Deferred Tax Liabilities	83.39	89	60.89	32.07	21.86	18.99
Other Long-Term Liabilities	64.71	41.19	27.33	43.32	55.02	39.29
Total Liabilities	6,280	5,704	5,619	6,302	9,683	6,954
Common Stock	1,860	1,865	1,865	1,866	1,866	1,848
Additional Paid-In Capital	6,108	6,126	6,135	6,131	6,127	6,046
Retained Earnings	1,794	1,784	3,449	2,847	1,839	1,251
Treasury Stock	-13.2	-33.31	-43.03	-66.89	-88.86	-
Comprehensive Income & Other	761.33	709.5	692.84	616.89	651.17	683.14
Total Common Equity	10,510	10,452	12,098	11,394	10,394	9,827
Minority Interest	390.32	401.96	411.53	361.42	408.12	375.47
Shareholders' Equity	10,900	10,854	12,510	11,755	10,802	10,203
Total Liabilities & Equity	17,180	16,558	18,129	18,057	20,484	17,157
Total Debt	4,049	3,643	3,226	3,395	6,830	3,018
Net Cash (Debt)	-2,382	-2,160	-2,206	-2,278	-6,168	-2,317
Net Cash Per Share	-1.28	-1.17	-1.19	-1.23	-3.33	-1.25
Filing Date Shares Outstanding	1,860	1,865	1,865	1,866	1,866	1,866
Total Common Shares Outstanding	1,860	1,865	1,865	1,866	1,866	1,848
Working Capital	1,132	893.51	2,509	2,046	578.01	186.63
Book Value Per Share	5.65	5.60	6.49	6.11	5.57	5.32
Tangible Book Value	9,539	9,484	11,123	10,399	9,176	8,638
Tangible Book Value Per Share	5.13	5.09	5.96	5.57	4.92	4.68
Buildings	-	4,447	4,678	4,534	-	4,613
Machinery	-	9,495	9,830	9,025	-	9,272
Construction In Progress	-	312.19	84.39	720.9	-	313.67

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.